The complete nucleotlde sequences of both rat liver and Walker 256 mammary carcinosarcoma tHNA Asn reveal that they are identical except for the nucleotide present in the wobble position of the anticodon loop. The rat liver tHNA-* 821 contains the Q nucleoside, whereas the tumour tHKA sn contains an unmodified guanosine. The tRNAs from both tissues also show significant quantitative differences in the chromatographic mobilities for isoaccepting species of tHKA Ae P, tRNA Asn , tENA In addition, chromatographic shifts upon cyanogen bromide treatment and analyses of the alkaline hydrolysates of these tHNAs demonstrate that those of tumour origin contain significantly less Q and Q* nucleoside than their normal rat liver counterparts.
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In addition, chromatographic shifts upon cyanogen bromide treatment and analyses of the alkaline hydrolysates of these tHNAs demonstrate that those of tumour origin contain significantly less Q and Q* nucleoside than their normal rat liver counterparts.
IKTRODUCTION
Transfer ENA is a pivotal molecule in protein synthesis which is capable of binding to a wide variety of RNAs (mHNA, 5S RNA, etc.) and proteins (aminoacyl tRNA synthetases, protein synthesis factors, tHNA modifying enzymes, etc.). These various interactions must be highly specific as any errors in protein synthesis would cause the formation of aberrant proteins with altered specificity. In recent years, our laboratory has attempted to understand the functional significance of modified nucleotides in normal mammalian tRNA. Toward this end we have reported the complete nucleotide sequences for human placenta tHKA [1 ] , human placenta tRNA [2] , human placenta tHNA^1^ [3] and rat liver tHNA Asn [4] . Since the nucleotide sequences of these tRNAs are identical to their counterparts in other mammalian tissues, except for minor differences in their degree of posttranscriptional modification, these homogenic [5] tRNAs are ideal candidates for studies on the functional significance of their partial modifications.
For example, our recent in vitro studies [6] demonstrated that the rlbothyRie midine content of mammalian tRNA can be correlated directly with its ability to function in a rat liver poly{r;)-directed poly(Hie) synthesis system.
Another approach to the functional significance of modified nucleotides in tRNA is to determine the structural alterations found by comparing the homogenic tRNAa isolated from tumour and normal tissues. The earlier work in this area has been reviewed [7] and more recent reports of alterations in tHNA chromatographic mobility have been published [5, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Only in a few instances [5, [8] [9] [10] [11] [12] [13] [14] [15] has the specific alteration been investigated fully enough to identify the structural change which caused the observed chromatographic shift in elution position. For example, the nucleotides Y [8] [9] [10] 23] and Q (or Q*) [5, [11] [12] [13] 24, 25] are altered in specific tRNAs isolated from various tissues. In addition, Kuchino and Borek [26] recently reported that the phenylalanlne tRNA from Novikoff hepatoma and Ehrlich ascites cells both contain increases in specific methylated bases, whereas other reports [8, 10] indicate that these tumour specific phenylalanine tHNAs lack the hypermodified "Y" base.
In this article we are reporting studies on the Aminex A-28 chromatographic analyses of rat liver and Walker 256 carcinosarcoma tHNA, their nucleoside composition analysis, and the complete nucleotide sequence comparison of the major species of both rat liver and Walker 256 carcinosarcoma tRNA n . Walker 256, a mammary carcinosarcoma propagated in SpragueDawley rats, has been used in many studies [27, 28] , although to date the tRNA from this tumour has not been investigated. Our results indicate that these two mammalian tRNA s have almost identical nucleotide sequences, but they differ in the nucleoside present in the wobble position of their anticodons, with the Q nucleoside present in the rat liver tRNA n and the G nucleoside present in the tumour tRNA
MATERIAIS AHD METHODS
Isolation, aminoacylation and separation of the isoaccepting aminoacyl tHMA species of rat liver and Walker 256 mtrnmnry carcinosarcoma tRHA on Aminex
A-28
Rat liver and Walker 256 mammary carcinosarcoma tissues were obtained from Sprague-Dawley Albino rats (strain AHS) through the courtesy of Grand Island Biological Co., Grand Island, Kew York. The tRNA was isolated by the pH 4.5 phenol extraction, bulk DEAE-cellulose procedure as described earlier [29] -Isolation of total aminoacyl t RT3A synthetases, preparative homologous aminoacylation and the subsequent purification of the aminoacyl tRIIA were as reported [13] .
The ^C-labelled and ^H-labelled aminoacyl tHNAs from normal rat liver and Walker 256 mammary carcinosarcoma, respectively, were cochromatographed on the anlon exchange resin Aminex-28 (Bio-Had. Laboratory, Richmond, California) which was pretreated, equilibrated and packed into a 0.5 cm x 30 cm stainless steel tube with Swagelock fittings top and bottom as previously described [13, 31 ] • The column was built and run at room temperature and the flow rate was maintained at 1 ml per 1.2 min per fraction using a Mil-Roy D pump, as described previously [13] . Approximately 20,000 CTM each of 14 C-and *H-labelled tRNAs (in all cases, except for Cys-tRNA in which ^C-Cys was used for both the normal and tumour tRNA, and each was Aquasol was pipetted into each fraction and the radioactivity was determined using the dual label channel in a Nuclear Chicago refrigerated Isocap 300 liquid scintillation counter.
In some experiments the tRNAs were aminoacylated using the heterologous enzymes, i.e. the rat liver tRNA was aminoacylated by the Walker 256 aminoacyl tRNA synthetase and the Walker 256 carcinosarcoma tRNA was aminoacylated by the rat liver aminoacyl tRNA synthetase, while in others the tRNAs were aminoacylated with their homologous enzymes but with reversed radioactive labels.
In a separate experiment the rat liver and the Walker 256 carcinosarcoma tRNAs were treated with three times sublimed cyanogen bromide [13] , aminoacylated and chromatographed on Aminex A-28 as described above.
Purification of the major isoacceptlng species of rat liver and Walker 256 mmmna-ry carcinosarcoma tRMA
The rat liver tffiJA Bn was isolated to greater than 80$ purity by fractionation on BD-cellulose, acylated dihydroxyl-borate (DBAE) cellulose, and EPC-5 as previously described [4] . Further purification to homogeneity was obtained by preparative polyacrylamide slab gel electrophoresis [4, [30] [31] [32] . The Walker 256 carcinosarcoma tRUA Sn was purified by a similar procedure [4] but the acylated DBAE-cellulose chromatography step was omitted, since this tRIIA lacks the Q nucleoside [13] .
Ribonucleaae T. fingerprint of rat liver and Walker 256 carcinosarccnnâ 11 on PEI-cellulose TLC
The ribonuclease T. digests were mapped on EEI-cellulose TLC employing the tritium post-labelling technique [33] [34] [35] [36] . Briefly, after complete digestion with RNase T.., the oligonucleotide fragments were treated with bacterial alkaline phosphatase in the presence of diethylpyrocarbonate, oxidized with sodium metaperiodate, and reduced with tritium-labelled borohydride. Following evaporation to dryness, the tritium-labelled oligonucleotldes were resolved by two dimensional PEI-cellulose TLC [36] . The first dimension was developed with a 0-0.6 M LiCl stepwise gradient. The second dimension was developed with a 0.2-3-8 M ammonium formate (pH 3-5) stepwise gradient. Film detection was by fluorography. Each oligonucleotide was further analysed by determining its 5' terminus [33, 34] , complete nucleotide composition [37] [38] [39] [40] , and in some cases its complete nucleotide sequence [33] [34] [35] [36] . Although the oligonucleotide C-O-Q-U-TJ-t A-A-C-C-Gp has been observed previously in the rat tRNA [4] , alterations in the structure of its Q base, upon treatment with periodate and borohydride, cause it to be undetectable by the tritium post-labelling technique.
The complete RNase T 1 and complete RNase A [4] digestion fragments of Asn rat liver and Walker 256 mammary carcinosarcoma tHKA were arranged in the unique cloverleaf secondary structure after analysis of the partial specific cleavage products of the 5 1 52 P-labelled tRNAs [4, [30] [31] [32] .
RESULTS

Comparison of isoacceptlng tHNAs from rat liver and Walker 256 carcinosarcoma tissues
The average yield and purity of the total crude tRNAs isolated from rat [29] . In addition, both tHNA preparations had similar levels of amino acid acceptor activity [13, 29] and all but four aminoacyl tRNA isoaccepting families gave similar Aminex A-28 [13, 41, 42] chromatographic elution profiles (data not shown). However, as can be seen in Figure 1 , relative quantitative differences were observed in the elution profiles of tRNA sn (Fig. 1a ), t&IA Asp ( Fig. 1d ), tRNA 318 ( Fig. 1g ) and tRHA^ ( Fig. 1j ). For example, Asn the tRIlA from normal rat liver consists of one major species and two minor species, whereas the tHNA from Walker 256 tumour consists of two major species and one minor species. A similar increase in later eluting species was obtained also for the tumour tRNA Asp , tRNA S and tHNA^1.
These quantitative differences are due to specific alterations in the tRNA distribution rather than to differences in aminoacylation or contamination of the radioactive amino acid labels. This was confirmed by their aminoacylation with the heterologous enzymes (Fig. 1b , e, h, k), by the reversal of the radioactive amino acids with the homologous enzymes (Fig. 1c, f concluded that the rat liver tRNA might contain Q nucleoside, whereas the Walker 256 carcinosarcoma tRNAs might lack the Q nucleoside.
Chromatography of mammalian tRNAs on acylated DBAE-cellulose
We previously reported the chromatographic properties of rat and Walker 256 tumour tRNAs on acylated KBAE-cellulose [13] . Briefly, for rat liver tRNAs, tRNA 318 had the greatest affinity for the acylated DBAE-cellulose matrix, whereas tRNA^1 had the lowest affinity for this matrix. Intermediate affinities were shown by tRNA 8n and tRNA SI> since both isoaccepting families contained species of tRNA with different affinities for the acylated DBAE-cellulose matrix. These data are consistent with the hypothesis that species of mammalian tHNA^1 8 , tHNA^1 1 and tRNA Asp contain the E. coll-like Q nucleoside whereas species of mammalian tRNA^1, tRNA 8n and tRHA P contain the Q* nucleoside [13, 47] .
When the results of the acylated DBAE-cellulose chromatography of rat liver tHNA [13] are compared to the results obtained in the cyanogen bromide treatment experiments (data not shown), we note that those mammalian tRHAs retained on acylated DBAE-cellulose are also sensitive to cyanogen bromide treatment. In addition, when the mammalian tHNA , partially purified by adsorption to acylated DBAE-cellulose, was aminoacylated and cochromatoHis graphed on Aminex A-28 with unfractionated aminoacyl tHHA , its elution position corresponded to that of the earlier eluting species in the unfractionated tHNA (data not shown).
In contrast to the results with rat liver tRNA, the Walker 256 carcinosarcoma tRNA showed a significantly lower affinity for the acylated DBAEcellulose matrix [13] . Considered together, the results reported earlier [13] , and those shown in Figure 1 , imply that the tumour tHNA lacks both Q, and Q* nucleosides but instead contains some other nucleoside in the wobble position [13] .
Direct analysis of Q and Q* nucleoside content of the mammalian tRNAs
We next attempted to determine directly the amount of Q (and Q*)
nucleoside present in rat liver and Walker 256 mammary carcinosarcoma tHNA by Dowex 1x8 column chromatography of a neutralised alkaline digest of the isolated tHNAs [12, 13] . A typical elution profile obtained from such an experiment has been reported earlier [13 ] • The peak corresponding to Qp (and Q»p) was first identified by its ultraviolet spectrum [24, 25] and was analysed further by two dimensional cellulose TLC [48] . The major components of this peak fraction from the alkaline digest of rat liver tHNA had mobilities corresponding to that published for both Qp and Q*p [12, 24, 25] . Since the peak in the elution profile containing Ap and Q*p obtained from rat tRNA was much larger than that obtained from Walker tRNA [13] , and since Qp and Q*p constitute at least 80^ of this peak (data not shown), these earlier results imply that Walker 256 mammary carcinosarcoma tRNA has reduced amounts of both hypermodified nucleosides. This direct evidence of the reduction in Q and Q* content of Walker tHNA is consistent with the results obtained from the Aminex A-28 and acylated DBAE-cellulose column Fig. 1 . Separation of the mammalian Q (and Q») containing aminoacyl tHNA lBoaccepting species of rat liver and their counterparts from Walker 256 mammary carclnosarcoma tRNA on Aminex A-28. In a, d, g and j, the tRNAs were aminoacylated with their homologous aminoacyl tHHA eynthetases. In b, e, h and k, the tRHAs were aminoacylated with their heterologous enzymes, and in c, f, i and 1 the tRtlAs. were aminoacylated with their homologous enzymes, but the radioactive labels were reversed. In all cases the methods employed were as described in Materials and Methods . The elution profiles shown are for the cochromatographed rat liver (a-a) and Walker 256 mammary carcinosarcoma (0-0) tHIAs. chromatography [13] discussed above.
Total base analysis of rat and Walker tRHA species
The results of total base analysis of normal rat liver and Walker 256 carcinosarcoma tHNAs employing the tritium post-labelling technique are shown in Table 1 . The base analysis of these tRNAs indicates that there is little difference in the base composition for the total tRNA from these two tissues, except that the rat liver tRNAs have a slightly greater proportion of m G, \\f, m C, D, m G and X, and a slightly smaller proportion of A.
Because this technique cannot be used to detect or analyse Q nucleoside, we employed the methods discussed earlier [12] to establish variation in the Q nucleoside content of rat liver when compared to Walker 256 tumour tENA [13] . as is the case with E. coll tRUAs [50, 51] . The presence of the X nucleoside [50] in the tumour tRnA Aen is surprising in the light of the observation [13] that this tumour tRIIA does not show the expected altered mobility on Molar ratios based on 75 nucleotides per tRNA as determined using the tritium post-labelling method [37-4O] . The total rat liver and Walker 256 mammary carcinosarcoma tRNAs were further purified by gel chromatography on a Sephadex G-100 column, thereby removing both high and low molecular weight contaminants prior to base analysis. The average values for ten complete analyses (X) and standard deviations (<r) are given.
Probability, P, as calculated using the students t-test, where:
The presence (+) of Q nucleoside was determined by Dowei 1x8 column chromatography as described [13] - Aminei A-28, after treatment with cyanogen bromide [11] . This lack of altered mobility could be due to differences in the resolving power of Aminei A-28 and RPC-5. It also might be that the Z nucleoside is altered by treat- 
and Z is an unknown modified nucleoside. ment with cyanogen bromide, which results in a compensatory change in the overall charge of the tRNA, thereby not affecting its elution position.
CONCLUSION
The results reported herein establish that Walker 256 mammary carcinosarcoma tRNA contains significantly less Q and Q* nucleoside when compared to normal rat liver tRNA, and that the major species of tumour tHNA contains a guanosine rather than a Q nucleoside in the wobble position of its anticodon. Investigation of the possible functional differences dependent on the presence of either G or Q as the wobble nucleoside in tRNA is now desirable because this structural modification may play an important role in the maintenance of Walker 256 mammary carcinosarcoma. Since tHNA plays a central role in protein synthesis, it would be of interest to study both the rate and sites of incorporation of amino acids using tRNAs which differ only in their wobble nucleosides. In addition, determining the binding specifi-i city of each of these tRNAs to selected codon sequences also might aid in elucidating the exact function of this Q to G substitution.
A recent report by Olsen and Penhoet [22] describing comparative studies of tRNA^1" from human placenta and HeLa cells indicates that no significant differences exist in the rate or site of incorporation of tyrosine into tryptic peptides of a-globin, even though there is a dramatic difference in the RPC-5 chromatographic elution profiles between these two tissue tRNAs. Although they too found an increase in a later eluting peak [15] I no nucleoside analysis was performed to elucidate the exact nature of the alteration causing the chromatographic mobility shifts. In another study, Briscoe et al. [21] isolated tRNA from SV40-induced hamster tumours, BHK2i/cl 13 cells in culture, certain carcinogen-induced tumours in Ehrlich ascites tumour, and a number of human carcinomas and adenocarcinomas. They found a distinct increase in the percentage of a late-eluting tRNA over that observed in non-malignant tissues, in other animal tumours, and in human melanomas and sarcomas. The codon-dependent ribosome binding ability of the late-eluting tRNA S P and an earlier eluting tHNA p were compared and found to be approximately the same. If the late-eluting peak in these studies [21, 22] is identical to our wobble-guanosine containing late-eluting peak, it would therefore seem that the function of these tRNAs in protein synthesis associated reactions is independent of the Q modification in the wobble position.
In an earlier report which employed triplet binding assays and the E. coli containing tRNAs, Haxada and Nisnimura [46] demonstrated that Q in the wobble position of the anticodon has a greater affinity for uridine than for cytoeine in codon-anticodon base pairing. More recently, Grosjean et al.
[52] examined the binding equilibrium between several highly purified tHNAs which contain complementary anticodons. These authors reported that the Q-U base pair increases stability of anticodon-anticodon interaction three-fold over that in an identical triplet sequence containing guanosine instead of Q.
In addition, the anticodon-anticodon interactions which resulted in a Q-C base pair were shown to be less stable than those involving a G-C base pair.
These results [46, 52] suggest the possibility that the presence of guanosine or Q in the anticodon wobble position of otherwise identical tHNAs could affect either the rate of protein synthesis or the sites of incorporation of the individual amino acids into a growing polypeptide chain. This is in contrast to the results obtained with the various mammalian tRNA [21 ] and the HeLa cell tENA * r [22] . Therefore, at present it seems that in protein synthesis the role of these Q (and Q*) or guanosine might play an important role in functions unrelated to protein synthesis. One such function is the use of specific tHNAs in the regulation of selected metabolic pathways [53] [54] [55] [56] [57] . In this regard, White et al. [5] demonstrated that there is an alteration in the Q nucleoside content during the life cycle of Drosophila, while
Jacobson [58] showed that the ability of tRNA Tyr to inhibit the activity of tryptophan pyrrolase depends on the presence of Q nucleoside in the tRNA. In addition, Ames and co-workers have demonstrated that the conversion of uridine to pseudouridine in the anticodon stem region of tRNA plays a role in the regulation of histidine biosynthesis [59, 60] .
Another role of tHNA is the ability of selected tRNA species to serve as primers during reverse transcription [61] [62] [63] [64] [65] [66] . The avian tRNA ^ has been shown to serve as the primer for both Rous Sarcoma (RSV) and the Avian Myeloblastosis Virus (AMV) reverse transcriptase, while the tRNA can serve as a primer for the murine leukaemic virus reverse transcriptase [61 ] . We recently observed (unpublished observation) that total Walker 256 mammary carcinosarcoma tRMA is a more effective primer than the total rat liver tRNA in the AMV reverse transcriptase reaction, although both tRNA preparations contain similar total levels of tRNA Trp and tRNA 1 * 0 . Further studies with highly purified Q-containing and guanosine-containing tHNAs will test the hypothesis that one function of Q in normal cellular tRNA is to block the ability of selected normal tHNAs to prime for reverse transcription. In addition, it might be that the tumour-specific tHNAs, by lacking the Q modification, then can be sequestered and serve as additional primers for the increased reverse transcriptase activity ascribed to several types of tumour tissue [67] [68] [69] -However, no direct evidence as yet has shown that the replacement of the Q (and Q*) nucleoside by guanosine plays an important role in any cellular function necessary for tumour maintenance.
In addition to the above mentioned studies, we also have compared the nucleotide sequences of rat liver, human liver and human placenta tRNA n (unpublished observation) and confirmed that the primary structures of these specific major isoaccepting tENA species are maintained throughout higher it might be that the tumour tissue lacks sufficient quantities of one or more of the enzymes or substrates required for Q (and Q*) biosynthesis [72-7 7] or that the tumour produces an inhibitor(s) of these enzymes. On the other hand, the presence or absence of Q nucleoside can be responsive to various growth conditions [11 ] , or it might be enzymatically labile and be replaced by guanosine [72] [73] [74] [75] [76] [77] -Now that evidence has been presented which establishes only a single structural alteration in a specific tumour tHNA, we should consider further experiments to test the validity of the above hypotheses. 
